Login / Signup

Adverse Events of Abiraterone Acetate vs Enzalutamide.

Leandro BlasMasaki ShiotaShigehiro TsukaharaShohei NagakawaTakashi MatsumotoMasatoshi Eto
Published in: Urology practice (2023)
In conclusion, our findings suggest that both drugs present a discrete and nonoverlapping toxicity profile that varies by System Organ Class and patient age. This data set confirms, for the most part, what has been reported in clinical trials as well as true real-world reports.
Keyphrases
  • clinical trial
  • prostate cancer
  • case report
  • electronic health record
  • oxidative stress
  • big data
  • adverse drug
  • phase ii
  • randomized controlled trial
  • machine learning
  • phase iii
  • double blind